Clinical Trial Update: A Phase I Clinical Study to Evaluate SM17 in Chinese Healthy Subjects and Patients With Moderate to Severe Atopic Dermatitis [Phase 1]

View source ↗

Summary

Phase I study evaluating SM17 in Chinese healthy subjects and patients with moderate to severe atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• SM17

Snippet

Sponsor: SinoMab BioScience Ltd | Conditions: Atopic Dermatitis | Phase 1 | Status: COMPLETED